Immunome, Inc.
€18.84
EUR
Last updated on --.
24h volume1.09M
24h highest19.2659 EUR
24h lowest17.9763 EUR
24h Price movement+1.18%
IMNM recent prices
24 Hours
+1.18%+€0.21922
30 days
-6.13%-€1.238
60 days
+10.35%+€1.745
90 days
+0.74%+€0.13841
Key data
Previous close18.6211 EUR
Market cap2.10B EUR
Volume1.09M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.7022 EUR
Net income (FY)-193.08M EUR
Revenue (FY)3.45M EUR
Last report date12 May 2026
About Immunome, Inc.
HeadquartersBOTHELL
Employees (FY)177.00
Revenue per employee (FY)19.50K EUR
Net income per employee (FY)-1.09M EUR
Listed onNasdaq
IMNM conversion tables
 |  |
|---|---|
| 0.5 IMNM | 9.420 EUR |
| 1 IMNM | 18.84 EUR |
| 5 IMNM | 94.2 EUR |
| 10 IMNM | 188.4 EUR |
| |
|---|---|
| 0.5 EUR | 0.026539 IMNM |
| 1 EUR | 0.053078 IMNM |
| 5 EUR | 0.26539 IMNM |
| 10 EUR | 0.53078 IMNM |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IMNM is trading at €18.84, +1.18% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IMNM stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IMNM is currently trading at €18.84, +1.18% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IMNM price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IMNM's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IMNM; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IMNM's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Immunome, Inc.'s market cap is currently 2.10B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.09M
24h highest19.2659 EUR
24h lowest17.9763 EUR
24h Price movement+1.18%
Start trade with IMNM Perpetual
Sign up to trade